Tampa biotech changes its name
May 28, 2019 - HedgePath Pharmaceuticals, a Tampa biotech working on cancer treatments, is changing its name to Inhibitor Therapeutics Inc. The new name reflects the company’s broader mission, a filing with the Securities and Exchange Commission said. The company, which trades over-the-counter, will change its ticker from HPPI to INTI. It also plans a reverse stock split, and said the move should increase the stock price so it can trade on the Nasdaq Capital Market or NYSE American exchange.